(NYSE: NGVT) Ingevity's forecast annual revenue growth rate of 1.08% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.32%.
Ingevity's revenue in 2025 is $1,350,300,000.On average, 1 Wall Street analysts forecast NGVT's revenue for 2025 to be $49,008,801,408, with the lowest NGVT revenue forecast at $49,008,801,408, and the highest NGVT revenue forecast at $49,008,801,408. On average, 1 Wall Street analysts forecast NGVT's revenue for 2026 to be $50,212,142,514, with the lowest NGVT revenue forecast at $50,212,142,514, and the highest NGVT revenue forecast at $50,212,142,514.
In 2027, NGVT is forecast to generate $51,707,202,676 in revenue, with the lowest revenue forecast at $51,707,202,676 and the highest revenue forecast at $51,707,202,676.